Looks promising after such a deep fall. Looks like BAL has been the target of “bear raid”. Can’t explain otherwise. They came up with higher guidance for FY18 and since then haven’t downgraded it. Given they have been caught out for non disclosure in the past, I don’t believe they would have kept any updates from the market. If that is the case they do know that they will be punished. So far only negative news has been around the delay in samr/CFDA approval and I think short sellers are/were pushing it down to make some $$$ while the instos used the low price to accumulate.
BAL Price at posting:
$10.31 Sentiment: Buy Disclosure: Held
